1. Home
  2. Analysis
  3. Valproate-sodium
  4. Conjunctivitis-aggravated

Valproate sodium and Conjunctivitis aggravated - a phase IV clinical study of FDA data

Summary:

Conjunctivitis aggravated is reported as a side effect among people who take Valproate sodium (valproate sodium), especially for people who are male, 40-49 old, have been taking the drug for 1 - 2 years also take Lorazepam, and have Depression.

The phase IV clinical study analyzes which people have Conjunctivitis aggravated when taking Valproate sodium. It is created by eHealthMe based on reports of 23,476 people who have side effects when taking Valproate sodium from the FDA, and is updated regularly.

What is Valproate sodium?

Valproate sodium has active ingredients of valproate sodium. It is often used in epilepsy. eHealthMe is studying from 24,044 Valproate sodium users. Check the latest studies of Valproate sodium.

What is Conjunctivitis aggravated?

Conjunctivitis aggravated (infection of conjunctiva) is found to be associated with 1,047 drugs and 366 conditions by eHealthMe. Check the latest studies of Conjunctivitis aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

23,476 people reported to have side effects when taking Valproate sodium.
Among them, 64 people (0.27%) have Conjunctivitis aggravated.

Could Valproate sodium cause Conjunctivitis aggravated?

Among these 64 people:

How long have people been on Valproate sodium when they have Conjunctivitis aggravated? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 25.0 %
  • 6 - 12 months: 25.0 %
  • 1 - 2 years: 37.5 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 12.5 %
  • 10+ years: 0.0 %

What is the gender of people who have Conjunctivitis aggravated when taking Valproate sodium? *

  • female: 46.88 %
  • male: 53.12 %

What is the age of people who have Conjunctivitis aggravated when taking Valproate sodium? *

  • 0-1: 6.25 %
  • 2-9: 10.42 %
  • 10-19: 10.42 %
  • 20-29: 2.08 %
  • 30-39: 20.83 %
  • 40-49: 37.5 %
  • 50-59: 2.08 %
  • 60+: 10.42 %

What are other drugs people take besides Valproate sodium? *

  1. Lorazepam: 18 people, 28.12%
  2. Trileptal: 17 people, 26.56%
  3. Amisulpride: 16 people, 25.00%
  4. Anafranil: 16 people, 25.00%
  5. Cymbalta: 16 people, 25.00%
  6. Gabapentin: 16 people, 25.00%
  7. Ludiomil: 16 people, 25.00%
  8. Risperdal: 16 people, 25.00%
  9. Abilify: 16 people, 25.00%
  10. Venlafaxine Hydrochloride: 16 people, 25.00%

What are other side effects people have besides Conjunctivitis aggravated? *

  1. Visual Impairment: 21 people, 32.81%
  2. Fever: 19 people, 29.69%
  3. Vision Blurred: 17 people, 26.56%
  4. Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 17 people, 26.56%
  5. Eye Irritation: 16 people, 25.00%
  6. Intestinal Obstruction: 16 people, 25.00%
  7. Psoriasis (immune-mediated disease that affects the skin): 16 people, 25.00%
  8. Constipation: 16 people, 25.00%
  9. Dry Eyes (lack of adequate tears): 16 people, 25.00%
  10. Erythema Multiforme (a type of hypersensitivity reaction): 14 people, 21.88%

What are the existing conditions these people have? *

  1. Depression: 16 people, 25.00%
  2. Affective Disorder (mental disorder): 3 people, 4.69%
  3. Neuropathy Peripheral (surface nerve damage): 3 people, 4.69%
  4. Allergies: 3 people, 4.69%
  5. Colon Cancer: 3 people, 4.69%
  6. Constipation: 3 people, 4.69%
  7. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 4.69%
  8. Schizoaffective Disorder (a mental disorder characterized by disordered thought): 3 people, 4.69%
  9. Psychotic Disorder: 3 people, 4.69%
  10. Thyroid Diseases: 3 people, 4.69%

* Approximation only. Some reports may have incomplete information.

Do you take Valproate sodium and have Conjunctivitis aggravated?

- Check whether Conjunctivitis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Valproate sodium:

Conjunctivitis aggravated treatments and more:

How severe was Conjunctivitis aggravated and when was it recovered:

Expand to all the drugs that have ingredients of valproate sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Valproate sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Conjunctivitis aggravated:

Browse all the conditions that are associated with Conjunctivitis aggravated:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on valproate sodium (the active ingredients of Valproate sodium) and Valproate sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.